Return to study ST001313 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
CL 68:2; [M-2H](2-); CL(18:1/16:0/18:1/16:0) ME306717 CL 18:1/16:0/18:1/16:0 --Reversed phase NEGATIVE ION MODE
CL 70:4; [M-2H](2-); CL(16:0/18:1/18:1/18:2) ME306564 CL 16:0/18:1/18:1/18:2 --Reversed phase NEGATIVE ION MODE
CL 72:5; [M-2H](2-); CL(18:0/18:2/18:1/18:2) ME306711 CL 18:0/18:2/18:1/18:2 --Reversed phase NEGATIVE ION MODE
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:1/18:2) ME306609 CL 18:1/18:2/18:1/18:2 --Reversed phase NEGATIVE ION MODE
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:2/18:1) ME306520 CL 18:1/18:2/18:2/18:1 --Reversed phase NEGATIVE ION MODE
CL 72:8; [M-2H](2-); CL(18:2/18:2/18:2/18:2) ME306685 CL 18:2/18:2/18:2/18:2 --Reversed phase NEGATIVE ION MODE
CL 74:2; [M-2H](2-); CL(18:0/18:1/18:0/20:1) ME306532 CL 18:0/18:1/18:0/20:1 --Reversed phase NEGATIVE ION MODE
CL 78:11; [M-2H](2-); CL(16:0/18:0/22:5/22:6) ME306665 CL 16:0/18:0/22:5/22:6 --Reversed phase NEGATIVE ION MODE


  logo